Close Menu

NEW YORK – 10x Genomics this week closed its initial public offering, with aggregate gross proceeds of $448.5 million, before discounts, commissions, and expenses. The single-cell analysis firm sold 11.5 million shares of its Class A common stock at an offering price of $39.00 per share. The underwriters fully exercised their option to purchase 1.5 million additional shares.

JP Morgan, Goldman Sachs, and Bank of America Merrill Lynch acted as lead joint book-running managers. Cowen acted as lead manager.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Department of Justice has proposed a rule change to enable DNA to be collected from migrants, the Associated Press reports.

Bernard Fisher, a surgeon who changed how breast cancer is treated, has died at 101, the New York Times reports.

Washington Post columnist writes that she is skeptical about DNA-based diets.

In PNAS this week: recurrent inactivation of DEPDC5 in gastrointestinal stromal tumors, taxonomic reliability of GenBank sequences, and more.